CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease. - Wikidata - awgldk - TriplyDB

CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.

CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.

http://www.wikidata.org/entity/Q51827467

about

A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells.DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16 A Suggested Approach to Simplify and Improve Cervical Screening in the United States.DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.Triage of HPV positive women in cervical cancer screening.JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix Validation of a DNA methylation HPV triage classifier in a screening sample Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women Somatic mutation in PIK3CA is a late event in cervical carcinogenesis.Decreased MALL expression negatively impacts colorectal cancer patient survival Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.Cervical cancer screening: on the way to a shift from cytology to full molecular screening.Epigenetics and cervical cancer: from pathogenesis to therapy.DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.Triage of high-risk HPV positive women in cervical cancer screening.Management of high-risk HPV-positive women for detection of cervical (pre)cancer.Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer.5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells.Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions.Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.Molecular events leading to HPV-induced high grade neoplasia.CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.Potential new biomarkers for squamous carcinoma of the uterine cervix.Detection of hypermethylated genes as markers for cervical screening in women living with HIV Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications

P2860

Q35125113-07644EEF-56B4-4C93-94A0-711613FCAB3E Q35636451-75CD3267-4BF4-4E9C-9B20-AF2C98DDC032 Q35678378-D5DE649D-ADDD-4A71-B742-7124BD29E43E Q35756579-9B4DE136-2D94-443E-BE97-CF2B959FFAA7 Q36372288-2C63FE69-60A5-4905-A020-AE018449B353 Q36407125-B597716E-2465-4E7A-B028-4A6F16F65207 Q36475094-F040C605-FFD1-442C-BD0C-9DBB1DD2EE2D Q36668105-FE8FE7EC-554B-482C-8D77-08B525CA3808 Q36679896-FE457141-29CF-4A27-B8D9-EDD1915E7AF4 Q36688981-15E212BC-77E5-417F-AE05-FD5A8844DCE7 Q36799858-C5349C30-BDD2-4036-B154-3A2F36161937 Q36852263-F2B960F5-E811-417A-9342-2B7F31C4BFB8 Q37082560-00317CEB-A92A-460A-85A4-FD2D1A0593DD Q37225710-B5DC0C0D-DE5C-4D0B-855C-4D1785DFBF4E Q37706679-1FF679B8-C58F-4F96-979B-1F1CA9259DC7 Q38180277-7740B3A1-6C6E-40B2-946F-50591102434C Q38189740-003FFB13-73ED-41EF-89C1-DA0AC7635775 Q38605348-8203B361-DDA3-4F17-9BF8-F69F1AD0E179 Q38824019-0AF24159-30CB-4505-A6F2-2638AEE45366 Q38837737-F47F3EC0-14A7-4692-986F-0542F931E398 Q40129828-E5D0B08C-4E80-43FB-95BD-47026FE3E00F Q40202976-E1606241-D38B-4BD6-AAA8-C2F21BB97DFD Q40256293-6C5F7A11-0EB6-46A2-9E68-94A4EA6FC16F Q40651597-54EF8315-DF9B-4CFE-B63F-1DDF87B28EA2 Q41027688-71F3049B-8283-4B05-8641-4193211F8BF9 Q41538167-50B37A20-1C17-4C1D-8982-131900CE791D Q41612137-5FEE5698-2FB0-437A-9ED5-883C44DCC048 Q42240383-1C422B41-DC07-43A8-AB2E-F5D6C94AB0B1 Q47598990-014EA425-56CD-46C7-861B-7CFD38A3628D Q53229949-C31378BB-3A0C-429B-BDD5-A800402E2309 Q55715397-8A0E349A-E549-4A33-980C-BFCF2692F5A8 Q56941300-91D48EBF-0DBA-4728-BF68-8644792AB842 Q58703195-98954330-B3D3-4A31-A63D-675BD2A1FE8F Q58738110-72BA35EA-FDC1-45AD-9636-E407832DEF1B

P2860

CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.

http://www.wikidata.org/entity/Q51827467

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

CADM1 and MAL promoter methyla ...... f underlying cervical disease.

@en

CADM1 and MAL promoter methyla ...... f underlying cervical disease.

@nl

type

label

CADM1 and MAL promoter methyla ...... f underlying cervical disease.

@en

CADM1 and MAL promoter methyla ...... f underlying cervical disease.

@nl

prefLabel

CADM1 and MAL promoter methyla ...... f underlying cervical disease.

@en

CADM1 and MAL promoter methyla ...... f underlying cervical disease.

@nl

P1433

Q51827467-C6D157AB-55AD-4E4F-BB88-06BBDAAA09EA

P1476

Q51827467-5C11FDCB-DE52-4749-B2F3-79D7DE27D92A

P2093

Q51827467-0C1EE2E7-E9E4-4BC2-9678-5005433885E6

Q51827467-3D75E41C-4F7A-4979-8610-8285E840D139

Q51827467-3FCAD0E4-C8BC-470C-B0C5-240F8027012A

Q51827467-4D9F5D78-2FBB-43CE-BB9E-76D51D793BC5

Q51827467-BACDB052-5431-4DEC-BBFD-7657EA32702F

Q51827467-D2C3DFAF-F153-4AA5-8F8F-E679B0C73A18

Q51827467-FEB15EA2-E652-4ACE-AE3D-27E88F26432C

P2860

Q51827467-13003E75-F4FD-4BC8-B875-FA0E90AB5DEB

Q51827467-13608B40-8A2C-4E15-85A6-2DFF80B30144

Q51827467-1C888B2E-3948-46D6-B0A9-62C05918ADB0

Q51827467-66D11E88-C482-46D8-88F2-9C9B3B41E45F

Q51827467-6BF12D4A-29B3-40A1-866D-15534FE211E6

Q51827467-6C960987-24F9-4374-A047-7D4FE5CD50B8

Q51827467-70D63DE6-AE13-403F-AFA8-E307184C78D2

Q51827467-8B5961E3-81E7-4FA7-8C93-C572F58EEFDB

Q51827467-8CBCBD75-AB9F-442D-A9C1-F7AD2231CAB1

Q51827467-8F4ADCA1-A064-4B90-9964-D2FFB54BDD29

P304

Q51827467-45D8B948-D270-4F8D-BDE4-74BD79AC8984

P31

Q51827467-1DB54574-98C3-44DA-B078-2F8F5A523324

P356

Q51827467-E8B11AA2-F073-4BC0-B278-9636590EA175

P433

Q51827467-C66C70C6-8C34-4B66-B4F7-DB6C45C0130C

P478

Q51827467-12A7FD02-DE26-4A71-80EC-C4922E8E66C8

P50

Q51827467-A6AA1A42-D42B-4007-990B-74B5C882577E

P577

Q51827467-35CDC346-4163-42D6-9A3A-8105F63C9F65

P5875

Q51827467-8C8C23D5-6737-44FD-BAB5-D5247E7CC382

P698

Q51827467-06A58F88-FB4A-4969-863C-B83012E2D903

P356

P1433

International Journal of Cancer

P1476

CADM1 and MAL promoter methyla ...... of underlying cervical disease

@en

P2093

Albertus T Hesselink

http://www.w3.org/2001/XMLSchema#string

Ate G J van der Zee

http://www.w3.org/2001/XMLSchema#string

Chris J L M Meijer

http://www.w3.org/2001/XMLSchema#string

Daniëlle A M Heideman

http://www.w3.org/2001/XMLSchema#string

G Bea A Wisman

http://www.w3.org/2001/XMLSchema#string

Mariska Bierkens

http://www.w3.org/2001/XMLSchema#string

Peter J F Snijders

http://www.w3.org/2001/XMLSchema#string

P2860

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.

A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.

The epidemiology of human papillomavirus infections.

HPV-mediated cervical carcinogenesis: concepts and clinical implications.

Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings.

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

P304

1293-1299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.28138

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Renske D. Steenbergen

P577

2013-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235777976

http://www.w3.org/2001/XMLSchema#string

P698

23456988

http://www.w3.org/2001/XMLSchema#string